Abstract
Major histocompatibility complex (MHC) class I - restricted CD8+ T cells play a critical role in the protective immunity against Mycobacterium tuberculosis (Mtb). However, only a few Mtb peptides recognized by MHC class Ia - restricted CD8+ T cells have been identified. Information on epitopes recognized by class Ib - restricted T cells is even more limited. M3 is an MHC class Ib molecule that preferentially presents N-formylated peptides to CD8+ T cells. Because bacteria initiate protein synthesis with N-formyl methionine, the unique binding specificity of M3 makes it especially suitable for presenting these particular bacterial epitopes. We have scanned the full sequence of the Mtb genome for NH2-terminal peptides that share features with other M3-binding peptides. Synthetic peptides corresponding to these sequences were tested for their ability to bind to M3 in an immunofluorescence-based peptide-binding assay. Four of the N-formylated Mtb peptides were able to elicit cytotoxic T lymphocytes (CTLs) from mice immunized with peptide-coated splenocytes. The Mtb peptide - specific, M3-restricted CTLs lysed the Mtb-infected macrophages effectively, suggesting that these N-formylated Mtb peptides are presented as the naturally processed epitopes by Mtb-infected cells. Furthermore, T cells from Mtb-infected lungs, spleen, and lymph nodes responded to N-formylated Mtb peptides in an M3-restricted manner. Taken together, our data suggest that M3-restricted T cells may participate in the immune response to Mtb.
Original language | English (US) |
---|---|
Pages (from-to) | 1213-1220 |
Number of pages | 8 |
Journal | Journal of Experimental Medicine |
Volume | 193 |
Issue number | 10 |
DOIs | |
State | Published - May 21 2001 |
Externally published | Yes |
Keywords
- Infection
- MHC
- Mycobacterium tuberculosis
- N-formylated peptides
- Vaccine
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology